Seeking Alpha

Covidien (COV) lands FDA clearance to market its Covidien Nellcor respiration rate software. The...

Covidien (COV) lands FDA clearance to market its Covidien Nellcor respiration rate software. The company plans a limited market release in U.S. hospitals starting next month.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs